Skip to main content
Year archive

Keeps Biopharma Inc. — 2021 filings

All 25 regulatory filings released by Keeps Biopharma Inc. (256940) in 2021, sourced directly from the official regulator.

25 Filings
2021 Period
2021 filings (25)
Filing Released Lang
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2021-12-30 Korean
주주총회소집결의(임시주주총회)
AGM Information
2021-12-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
전환가액의조정
Share Issue/Capital Change
2021-11-15 Korean
전환청구권행사
Share Issue/Capital Change
2021-10-21 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-08-31 Korean
증권발행결과(자율공시)
Capital/Financing Update
2021-08-13 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2021-08-10 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2021-07-19 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-07-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-06-07 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
전환청구권행사
Share Issue/Capital Change
2021-04-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-30 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-22 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-15 Korean
주주총회소집공고
AGM Information
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-09 Korean
주주총회소집결의
AGM Information
2021-03-09 Korean